EUVIMEDEUVIMED entdecken
Crossref

Potential of Cordyceps sinensis in the supportive treatment of breast cancer

Paraskeva Mancheva, Denitsa Grozdeva, Nikolay Conev, Bistra Galunska

Scripta Scientifica Medica · 18.02.2026 · 58 (1) · 29-37

DOI: 10.14748/f40f6g69 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scripta Scientifica Medica, online erschienen am 18.02.2026. Verfasst von Paraskeva Mancheva und 3 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer in modern medicine and practice is considered a chronic disease and requires long-term maintenance treatment. Taking in mind the unwanted effects of chemotherapy, it is necessary for the ongoing therapy to be restorative, detoxifying, and immunomodulatory. The inclusion of dietary supplements with adequate bioavailability and a broad spectrum of action (adaptogens) is a common practice. Cordyceps sinensis is an integral part of Chinese national phytotherapeutic pharmacy and recently its use as an adjuvant therapy for neoplastic diseases has been increasing worldwide. In Bulgaria, C. sinensis is registered as a dietary supplement, but its proven therapeutic power with adequate bioavailability assumes that it should be prescribed under medical supervision to ensure proper and effective use and therapy optimization. The benefits of integrating C. sinensis into clinical practice are directed to preventing complications and relapses of oncological and chronic diseases and to its usage as an adjuvant therapy. C. sinensis, when used simultaneously with pharmacological treatment, potentiates the drug effects and allows therapy optimization and overcoming of adverse drug reactions. The therapeutic capabilities of the drug may be limited in cases where it is used alone, rather than in synergy during the active treatment phase. There are opportunities for its inclusion as adjuvant therapy in patients with breast cancer. The aim of the current study is to explore and present the benefits of C. sinensis in the supportive treatment of breast cancer patients.

Zitieren

APA

Mancheva, P., Grozdeva, D., Conev, N., & Galunska, B. (2026). Potential of Cordyceps sinensis in the supportive treatment of breast cancer. Scripta Scientifica Medica, 58(1), 29-37. https://doi.org/10.14748/f40f6g69

Vancouver

Mancheva P, Grozdeva D, Conev N, Galunska B. Potential of Cordyceps sinensis in the supportive treatment of breast cancer. Scripta Scientifica Medica. 2026;58(1):29-37. doi:10.14748/f40f6g69

BibTeX
@article{Mancheva2026,
  author = {Mancheva, Paraskeva and Grozdeva, Denitsa and Conev, Nikolay and Galunska, Bistra},
  title = {Potential of Cordyceps sinensis in the supportive treatment of breast cancer},
  journal = {Scripta Scientifica Medica},
  year = {2026},
  volume = {58},
  number = {1},
  pages = {29--37},
  doi = {10.14748/f40f6g69}
}
Kostenlos starten →